Evidence for kinase inhibitor activity in acute myeloid leukaemia

1 Views
administrator
administrator
07/04/23

Visit http://www.ecancer.org for more

Dr Ehninger (University Hospital Dresden, Dresden, Germany) talks to ecancertv at EHA 2015 about the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next